Skip to main content
Top
Published in: Clinical and Translational Oncology 2/2014

01-02-2014 | Educational Series - Red Series

Renal cell carcinoma in pregnancy: a rare coexistence

Authors: S. Boussios, N. Pavlidis

Published in: Clinical and Translational Oncology | Issue 2/2014

Login to get access

Abstract

Renal cell carcinoma (RCC) is rarely diagnosed during pregnancy and its management represents a real challenge. As the symptomatology might mimic other common pregnancy-related disorders, the diagnosis is often delayed. RCC should be considered in women of childbearing age who present with recurrent or refractory urinary tract symptoms, flank pain, or a palpable mass. Ultrasound appears to be the imaging procedure of choice followed by the magnetic resonance imaging for evaluating the urinary system in pregnant women. The probability of cure is directly related to the stage or degree of tumor dissemination. Surgical resection is the mainstay of treatment.
Literature
1.
go back to reference Pentheroudakis G, Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer. 2006;42(2):126–40.PubMedCrossRef Pentheroudakis G, Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer. 2006;42(2):126–40.PubMedCrossRef
3.
go back to reference Pentheroudakis G, Pavlidis N. Gastrointestinal, urologic and lung malignancies during pregnancy. Recent Results Cancer Res. 2008;178:137–64.PubMedCrossRef Pentheroudakis G, Pavlidis N. Gastrointestinal, urologic and lung malignancies during pregnancy. Recent Results Cancer Res. 2008;178:137–64.PubMedCrossRef
4.
go back to reference Simon I, Rorive S, Kirkpatrick C, Roumeguere T, Nortier JL. Clear cell renal carcinoma presenting as a bleeding cyst in pregnancy: inaugural manifestation of a von Hippel–Lindau disease. Clin Nephrol. 2008;69(3):224–8.PubMedCrossRef Simon I, Rorive S, Kirkpatrick C, Roumeguere T, Nortier JL. Clear cell renal carcinoma presenting as a bleeding cyst in pregnancy: inaugural manifestation of a von Hippel–Lindau disease. Clin Nephrol. 2008;69(3):224–8.PubMedCrossRef
5.
go back to reference Bovio IM, Allan RW, Oliai BR, Hampton T, Rush DS. Xp11.2 translocation renal carcinoma with placental metastasis: a case report. Int J Surg Pathol. 2011;19(1):80–3.PubMed Bovio IM, Allan RW, Oliai BR, Hampton T, Rush DS. Xp11.2 translocation renal carcinoma with placental metastasis: a case report. Int J Surg Pathol. 2011;19(1):80–3.PubMed
6.
go back to reference Van der Veldt AA, Van Wouwe M, Van den Eertwegh AJ, Van Moorselaar RJ, Van Geijn HP. Metastatic renal cell cancer in a 20-year-old pregnant woman. Urology. 2008;72(4):775. Van der Veldt AA, Van Wouwe M, Van den Eertwegh AJ, Van Moorselaar RJ, Van Geijn HP. Metastatic renal cell cancer in a 20-year-old pregnant woman. Urology. 2008;72(4):775.
7.
go back to reference Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control. 1993;4(2):101–10.PubMedCrossRef Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control. 1993;4(2):101–10.PubMedCrossRef
8.
go back to reference Kamat AM, Shock RP, Naya Y, Rosser CJ, Slaton JW, Pisters LL. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology. 2004;63(1):46–50.PubMedCrossRef Kamat AM, Shock RP, Naya Y, Rosser CJ, Slaton JW, Pisters LL. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology. 2004;63(1):46–50.PubMedCrossRef
9.
go back to reference Mellemgaard A, Engholm G, McLaughlin JK, Olsen JH. Risk factors for renal-cell carcinoma in Denmark. III. Role of weight, physical activity and reproductive factors. Int J Cancer. 1994;56(1):66–71.PubMedCrossRef Mellemgaard A, Engholm G, McLaughlin JK, Olsen JH. Risk factors for renal-cell carcinoma in Denmark. III. Role of weight, physical activity and reproductive factors. Int J Cancer. 1994;56(1):66–71.PubMedCrossRef
10.
go back to reference Sion-Vardi N, Kaneti J, Segal-Abramson T, Giat J, Levy J, Sharoni Y. Gonadotropin-releasing hormone specific binding sites in normal and malignant renal tissue. J Urol. 1992;148:1568–70.PubMed Sion-Vardi N, Kaneti J, Segal-Abramson T, Giat J, Levy J, Sharoni Y. Gonadotropin-releasing hormone specific binding sites in normal and malignant renal tissue. J Urol. 1992;148:1568–70.PubMed
11.
go back to reference Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R. Estrogen receptor alpha polymorphisms and renal cell carcinoma—a possible risk. Mol Cell Endocrinol. 2003;202:109–16.PubMedCrossRef Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R. Estrogen receptor alpha polymorphisms and renal cell carcinoma—a possible risk. Mol Cell Endocrinol. 2003;202:109–16.PubMedCrossRef
12.
go back to reference Concolino G, Lubrano C, Ombres M, Santonati A, Flammia GP, Di Silverio F. Acquired cystic kidney disease: the hormonal hypothesis. Urology. 1993;41:170–5.PubMedCrossRef Concolino G, Lubrano C, Ombres M, Santonati A, Flammia GP, Di Silverio F. Acquired cystic kidney disease: the hormonal hypothesis. Urology. 1993;41:170–5.PubMedCrossRef
13.
go back to reference Ronchi E, Pizzocaro G, Miodini P, Piva L, Salvioni R, Di Fronzo G. Steroid hormone receptors in normal and malignant human renal tissue: relationship with progestin therapy. J Steroid Biochem. 1984;21:329–35.PubMedCrossRef Ronchi E, Pizzocaro G, Miodini P, Piva L, Salvioni R, Di Fronzo G. Steroid hormone receptors in normal and malignant human renal tissue: relationship with progestin therapy. J Steroid Biochem. 1984;21:329–35.PubMedCrossRef
14.
15.
go back to reference Neuringer JR, Brenner BM. Glomerular hypertension: cause and consequence of renal injury. J Hypertens. 1992;10:91–7.CrossRef Neuringer JR, Brenner BM. Glomerular hypertension: cause and consequence of renal injury. J Hypertens. 1992;10:91–7.CrossRef
16.
go back to reference Lindblad P, Chow WH, Chan J, Bergstrom A, Wolk A, Gridley G, et al. The role of diabetes mellitus in the etiology of renal cell cancer. Diabetologia. 1999;42:107–12.PubMedCrossRef Lindblad P, Chow WH, Chan J, Bergstrom A, Wolk A, Gridley G, et al. The role of diabetes mellitus in the etiology of renal cell cancer. Diabetologia. 1999;42:107–12.PubMedCrossRef
17.
go back to reference Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. Cancer. 1971;28:1165–8.PubMedCrossRef Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. Cancer. 1971;28:1165–8.PubMedCrossRef
18.
go back to reference Ney C, Posner AC, Ehrlich JC. Tubular adenoma of the kidney during pregnancy. Obstet Gynecol. 1971;37:267–76.PubMed Ney C, Posner AC, Ehrlich JC. Tubular adenoma of the kidney during pregnancy. Obstet Gynecol. 1971;37:267–76.PubMed
19.
go back to reference Donald I. Practical obstetrical problems. London: Lloyd-Luke; 1979. p. 336. Donald I. Practical obstetrical problems. London: Lloyd-Luke; 1979. p. 336.
20.
go back to reference Warshauer DM, McCarthy SM, Street L, Bookbinder MJ, Glickman MG, Richter J, et al. Detection of renal masses: sensitivities and specificities of excretory urography, linear tomography, US, and CT. Radiology. 1988;169:363–5.PubMed Warshauer DM, McCarthy SM, Street L, Bookbinder MJ, Glickman MG, Richter J, et al. Detection of renal masses: sensitivities and specificities of excretory urography, linear tomography, US, and CT. Radiology. 1988;169:363–5.PubMed
21.
go back to reference Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol. 1997;70:130–9.PubMed Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol. 1997;70:130–9.PubMed
22.
go back to reference Loughlin KR. The management of urological malignancies during pregnancy. Br J Urol. 1995;76(5):639–44.PubMedCrossRef Loughlin KR. The management of urological malignancies during pregnancy. Br J Urol. 1995;76(5):639–44.PubMedCrossRef
23.
go back to reference Yin L, Zhang D, Teng J, Xu D. Retroperitoneal laparoscopic radical nephrectomy for renal cell carcinoma during pregnancy. Urol Int. 2013;90(4):487–9.PubMedCrossRef Yin L, Zhang D, Teng J, Xu D. Retroperitoneal laparoscopic radical nephrectomy for renal cell carcinoma during pregnancy. Urol Int. 2013;90(4):487–9.PubMedCrossRef
24.
go back to reference O’Connor JP, Biyani CS, Taylor J, Agarwal V, Curley PJ, Browning AJ. Laparoscopic nephrectomy for renal-cell carcinoma during pregnancy. J Endourol. 2004;18(9):871–4.PubMedCrossRef O’Connor JP, Biyani CS, Taylor J, Agarwal V, Curley PJ, Browning AJ. Laparoscopic nephrectomy for renal-cell carcinoma during pregnancy. J Endourol. 2004;18(9):871–4.PubMedCrossRef
25.
go back to reference Lee D, Abraham N. Laparoscopic radical nephrectomy during pregnancy: case report and review of the literature. J Endourol. 2008;22(3):517–8.PubMedCrossRef Lee D, Abraham N. Laparoscopic radical nephrectomy during pregnancy: case report and review of the literature. J Endourol. 2008;22(3):517–8.PubMedCrossRef
26.
27.
go back to reference Hiratsuka M, Minakami H, Koshizuka S, Sato I. Administration of interferon-alpha during pregnancy: effects on fetus. J Perinat Med. 2000;28(5):372–6.PubMedCrossRef Hiratsuka M, Minakami H, Koshizuka S, Sato I. Administration of interferon-alpha during pregnancy: effects on fetus. J Perinat Med. 2000;28(5):372–6.PubMedCrossRef
28.
go back to reference Ozaslan E, Yilmaz R, Simsek H, Tatar G. Interferon therapy for acute hepatitis C during pregnancy. Ann Pharmacother. 2002;36(11):1715–8.PubMedCrossRef Ozaslan E, Yilmaz R, Simsek H, Tatar G. Interferon therapy for acute hepatitis C during pregnancy. Ann Pharmacother. 2002;36(11):1715–8.PubMedCrossRef
29.
go back to reference Shiraishi H, Hayakawa S, Satoh K. Murine experimental abortion by IL-2 administration is caused by activation of cytotoxic T lymphocytes and placental apoptosis. J Clin Lab Immunol. 1996;48(3):93–108.PubMed Shiraishi H, Hayakawa S, Satoh K. Murine experimental abortion by IL-2 administration is caused by activation of cytotoxic T lymphocytes and placental apoptosis. J Clin Lab Immunol. 1996;48(3):93–108.PubMed
30.
go back to reference Rezaei A, Dabbagh A. T-helper-1 cytokines increase during early pregnancy in women with a history of recurrent spontaneous abortion. Med Sci Monit. 2002;8:CR607–10. Rezaei A, Dabbagh A. T-helper-1 cytokines increase during early pregnancy in women with a history of recurrent spontaneous abortion. Med Sci Monit. 2002;8:CR607–10.
31.
go back to reference Kabat GC, Silvera SA, Miller AB, Rohan TE. A cohort study of reproductive and hormonal factors and renal cell cancer risk in women. Br J Cancer. 2007;96(5):845–9.PubMedCentralPubMedCrossRef Kabat GC, Silvera SA, Miller AB, Rohan TE. A cohort study of reproductive and hormonal factors and renal cell cancer risk in women. Br J Cancer. 2007;96(5):845–9.PubMedCentralPubMedCrossRef
32.
go back to reference Fynn J, Venyo AK. Renal cell carcinoma presenting as hypertension in pregnancy. J Obstet Gynaecol. 2004;24(7):821–2.PubMedCrossRef Fynn J, Venyo AK. Renal cell carcinoma presenting as hypertension in pregnancy. J Obstet Gynaecol. 2004;24(7):821–2.PubMedCrossRef
33.
34.
go back to reference Stojnić J, Jeremic K, Petković S, Lazović G, Stefanović A. Renal cell carcinoma in pregnancy: a case report. Eur J Gynaecol Oncol. 2009;30(3):347–9.PubMed Stojnić J, Jeremic K, Petković S, Lazović G, Stefanović A. Renal cell carcinoma in pregnancy: a case report. Eur J Gynaecol Oncol. 2009;30(3):347–9.PubMed
35.
go back to reference Pomara G, Salinitri G, Nesi G, Maio E, Minervini A, Gammazza AM, et al. P53 and Ki-67 expression in renal cell carcinomas of pregnant women and their correlation with prognosis: a pilot study. Int J Gynecol Cancer. 2008;18(1):132–5.PubMedCrossRef Pomara G, Salinitri G, Nesi G, Maio E, Minervini A, Gammazza AM, et al. P53 and Ki-67 expression in renal cell carcinomas of pregnant women and their correlation with prognosis: a pilot study. Int J Gynecol Cancer. 2008;18(1):132–5.PubMedCrossRef
36.
go back to reference Buda A, Pizzocaro G, Ceruti P, Salvioni R, Battistello M, Vergani P. Case report: renal cell carcinoma presenting as hypertension in pregnancy. Arch Gynecol Obstet. 2008;277(3):263–5.PubMedCrossRef Buda A, Pizzocaro G, Ceruti P, Salvioni R, Battistello M, Vergani P. Case report: renal cell carcinoma presenting as hypertension in pregnancy. Arch Gynecol Obstet. 2008;277(3):263–5.PubMedCrossRef
37.
go back to reference Stroup SP, Altamar HO, L’Esperance JO, Auge BK. Retroperitoneoscopic radical nephrectomy for renal-cell carcinoma during twin pregnancy. J Endourol. 2007;21(7):735–7.PubMedCrossRef Stroup SP, Altamar HO, L’Esperance JO, Auge BK. Retroperitoneoscopic radical nephrectomy for renal-cell carcinoma during twin pregnancy. J Endourol. 2007;21(7):735–7.PubMedCrossRef
38.
go back to reference van Basten JP, Knipscheer B, de Kruif J. Case report: retroperitoneoscopic tumor nephrectomy during pregnancy. J Endourol. 2006;20(3):186–7.PubMedCrossRef van Basten JP, Knipscheer B, de Kruif J. Case report: retroperitoneoscopic tumor nephrectomy during pregnancy. J Endourol. 2006;20(3):186–7.PubMedCrossRef
39.
go back to reference Casella R, Ferrier C, Giudici G, Dickenmann M, Giannini O, Hösli I, et al. Surgical management of renal cell carcinoma during the second trimester of pregnancy. Urol Int. 2006;76(2):180–1.PubMedCrossRef Casella R, Ferrier C, Giudici G, Dickenmann M, Giannini O, Hösli I, et al. Surgical management of renal cell carcinoma during the second trimester of pregnancy. Urol Int. 2006;76(2):180–1.PubMedCrossRef
40.
go back to reference Sainsbury DC, Dorkin TJ, MacPhail S, Soomro NA. Laparoscopic radical nephrectomy in first-trimester pregnancy. Urology. 2004;64(6):1231.e7–8. Sainsbury DC, Dorkin TJ, MacPhail S, Soomro NA. Laparoscopic radical nephrectomy in first-trimester pregnancy. Urology. 2004;64(6):1231.e7–8.
41.
go back to reference Guven S, Guvendag Guven ES, Islamoglu E, Gunalp GS, Ozen H. Successful management of chromophobe type renal cell carcinoma in pregnancy. Aust N Z J Obstet Gynaecol. 2004;44(4):362–3. Guven S, Guvendag Guven ES, Islamoglu E, Gunalp GS, Ozen H. Successful management of chromophobe type renal cell carcinoma in pregnancy. Aust N Z J Obstet Gynaecol. 2004;44(4):362–3.
42.
go back to reference Cegłowska A, Michalski A. Renal cell carcinoma during pregnancy. Ginekol Pol. 2004;75(2):145–9.PubMed Cegłowska A, Michalski A. Renal cell carcinoma during pregnancy. Ginekol Pol. 2004;75(2):145–9.PubMed
43.
go back to reference Armah HB, Parwani AV. Xp11.2 translocation renal cell carcinoma. Arch Pathol Lab Med. 2010;134(1):124–9.PubMed Armah HB, Parwani AV. Xp11.2 translocation renal cell carcinoma. Arch Pathol Lab Med. 2010;134(1):124–9.PubMed
44.
go back to reference Bettez M, Carmel M, Temmar R, Côté AM, Sauvé N, Asselah J, et al. Fatal fast-growing renal cell carcinoma during pregnancy. J Obstet Gynaecol Can. 2011;33(3):258–61.PubMed Bettez M, Carmel M, Temmar R, Côté AM, Sauvé N, Asselah J, et al. Fatal fast-growing renal cell carcinoma during pregnancy. J Obstet Gynaecol Can. 2011;33(3):258–61.PubMed
45.
go back to reference Chkhotua A, Managadze L, Pertia A. Metastasis of renal cell carcinoma to contralateral adrenal gland: case report and review of the literature. Georgian Med News. 2012;212:12–8.PubMed Chkhotua A, Managadze L, Pertia A. Metastasis of renal cell carcinoma to contralateral adrenal gland: case report and review of the literature. Georgian Med News. 2012;212:12–8.PubMed
Metadata
Title
Renal cell carcinoma in pregnancy: a rare coexistence
Authors
S. Boussios
N. Pavlidis
Publication date
01-02-2014
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 2/2014
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-013-1105-2

Other articles of this Issue 2/2014

Clinical and Translational Oncology 2/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine